Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Pulse Biosciences stock

Own Pulse Biosciences stock in just a few minutes.

Pulse Biosciences, Inc is a medical instruments & supplies business based in the US. Pulse Biosciences shares (PLSE) are listed on the NASDAQ and all prices are listed in US Dollars. Pulse Biosciences employs 95 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Pulse Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PLSE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Pulse Biosciences share price

Use our graph to track the performance of PLSE stocks over time.

Pulse Biosciences shares at a glance

Information last updated 2021-04-23.
52-week range$7.73 - $45.82
50-day moving average $23.81
200-day moving average $22.76
Wall St. target price$43.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.17

Buy Pulse Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Pulse Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Pulse Biosciences financials

Gross profit TTM $0
Return on assets TTM -75.06%
Return on equity TTM -185.9%
Profit margin 0%
Book value $0.90
Market capitalisation $550 million

TTM: trailing 12 months

Shorting Pulse Biosciences shares

There are currently 1.3 million Pulse Biosciences shares held short by investors – that's known as Pulse Biosciences's "short interest". This figure is 0.9% up from 1.3 million last month.

There are a few different ways that this level of interest in shorting Pulse Biosciences shares can be evaluated.

Pulse Biosciences's "short interest ratio" (SIR)

Pulse Biosciences's "short interest ratio" (SIR) is the quantity of Pulse Biosciences shares currently shorted divided by the average quantity of Pulse Biosciences shares traded daily (recently around 120036.99261993). Pulse Biosciences's SIR currently stands at 10.84. In other words for every 100,000 Pulse Biosciences shares traded daily on the market, roughly 10840 shares are currently held short.

However Pulse Biosciences's short interest can also be evaluated against the total number of Pulse Biosciences shares, or, against the total number of tradable Pulse Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pulse Biosciences's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Pulse Biosciences shares in existence, roughly 50 shares are currently held short) or 0.079% of the tradable shares (for every 100,000 tradable Pulse Biosciences shares, roughly 79 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Pulse Biosciences.

Find out more about how you can short Pulse Biosciences stock.

Pulse Biosciences share dividends

We're not expecting Pulse Biosciences to pay a dividend over the next 12 months.

Pulse Biosciences share price volatility

Over the last 12 months, Pulse Biosciences's shares have ranged in value from as little as $7.73 up to $45.82. A popular way to gauge a stock's volatility is its "beta".

PLSE.US volatility(beta: 1.68)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pulse Biosciences's is 1.6809. This would suggest that Pulse Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Pulse Biosciences overview

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue primarily for dermatology applications by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site